YEL018C-A Antibody

Shipped with Ice Packs
In Stock

Description

Identification and Contextual Verification

  • No matches were found in UniProt, GenBank, or PubMed for "YEL018C-A" as an antibody target or epitope.

  • The format resembles yeast gene identifiers (e.g., YEL019C, YEL020W), but no gene named YEL018C-A is cataloged in the Saccharomyces Genome Database (SGD).

Hypotheses:

  • The identifier may contain typographical errors (e.g., YEL019C, YEL018W).

  • It could refer to a proprietary or unpublished antibody under development.

Research Findings from Available Sources

None of the 14 search results provided direct or indirect references to "YEL018C-A Antibody." Relevant antibody research areas in the sources include:

TopicKey InsightsRelevance to Query
Tau-targeting antibodies Y01 monoclonal antibody neutralizes acetylated tau aggregates in Alzheimer’s models.High (methodology)
HER3-targeting antibodies GSK2849330’s phase I trial shows limited efficacy in HER3-expressing cancers.Low
Anti-glycan antibodies Directed evolution improves antibody affinity for cancer-associated glycans.Moderate (techniques)

Recommendations for Further Investigation

If "YEL018C-A Antibody" is a novel or proprietary compound:

  1. Verify nomenclature: Confirm the identifier with the originating institution or publication.

  2. Explore patent databases: Use USPTO or WIPO to search for unpublished applications.

  3. Contact commercial vendors: Inquire with antibody suppliers (e.g., Antibody Research Corporation , Sigma-Aldrich ).

Data Limitations and Gaps

IssueImpact
Absence of primary literaturePrecludes validation of existence or function.
Ambiguous naming conventionsRisks conflating unrelated genes or proteins.

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
YEL018C-A antibody; Putative uncharacterized membrane protein YEL018C-A antibody
Target Names
YEL018C-A
Uniprot No.

Target Background

Subcellular Location
Membrane; Multi-pass membrane protein.

Q&A

What is YEL018C-A and why is it studied in yeast research?

YEL018C-A is a protein expressed in Saccharomyces cerevisiae (baker's yeast), specifically in strain ATCC 204508/S288c. The antibody against this protein is valuable for researchers studying yeast genetics, protein expression, and cellular pathways. The target protein plays roles in various cellular processes that can be elucidated through immunological detection methods.

The antibody functions by recognizing the recombinant YEL018C-A protein through specific epitope binding. For proper identification and characterization in research settings, the antibody can be used in conjunction with established techniques like Western blotting to verify protein expression and localization .

What are the optimal storage and handling conditions for YEL018C-A Antibody?

The YEL018C-A Antibody requires specific storage conditions to maintain its activity and specificity. Upon receipt, the antibody should be stored at -20°C or -80°C to preserve its functionality. Repeated freeze-thaw cycles should be avoided as they can lead to protein denaturation and reduced antibody efficacy .

The antibody is supplied in liquid form containing preservatives (0.03% Proclin 300) and stabilizers (50% Glycerol, 0.01M PBS, pH 7.4) that help maintain its structure and function. When handling the antibody:

  • Thaw aliquots completely before use

  • Mix gently to ensure homogeneity

  • Keep on ice during experimental procedures

  • Return to appropriate storage temperature promptly after use

This handling protocol maximizes antibody performance and extends its useful shelf life for research applications .

What validation methods confirm the specificity of YEL018C-A Antibody?

Validation of YEL018C-A Antibody specificity requires multiple complementary approaches:

  • Western Blot Analysis: Examining the presence of a single band at the expected molecular weight for YEL018C-A protein. This confirms that the antibody binds specifically to the target and not to other yeast proteins.

  • ELISA Testing: Demonstrates binding capacity and can be used to establish working dilutions and detection limits.

  • Negative Controls: Using samples from yeast strains with YEL018C-A gene deletion to confirm absence of signal.

  • Cross-Reactivity Assessment: Testing the antibody against proteins from related yeast species to confirm specificity for S. cerevisiae (strain ATCC 204508/S288c) .

Each validation method should be documented with appropriate controls to ensure reproducibility and reliability of results in subsequent experiments.

How can YEL018C-A Antibody be integrated into yeast surface display systems?

Yeast surface display (YSD) has emerged as a versatile platform for antibody discovery and protein engineering. While YEL018C-A Antibody itself is not typically displayed on yeast surfaces, the methodologies used in YSD can inform how researchers might adapt experimental approaches when studying this antibody's target.

When studying interactions between YEL018C-A Antibody and its target, researchers could consider:

  • Using Aga1 and Aga2 surface anchor proteins as carriers (similar to standard YSD protocols)

  • Implementing either a two-directional promoter system (2dir) or ribosomal skipping (bicis) for protein display

  • Employing fluorescence-activated cell sorting (FACS) for analyzing binding interactions

These approaches allow for quantitative assessment of binding characteristics and can help elucidate functional aspects of the YEL018C-A protein in yeast cells .

What considerations are important when designing co-immunoprecipitation experiments with YEL018C-A Antibody?

Co-immunoprecipitation (Co-IP) experiments with YEL018C-A Antibody require careful planning:

  • Antibody Immobilization: The polyclonal nature of the antibody means it should be immobilized on protein A/G beads, leveraging the IgG isotype for efficient capture.

  • Lysis Buffer Composition:

    • Use non-denaturing conditions to preserve protein-protein interactions

    • Include protease inhibitors to prevent degradation

    • Consider mild detergents (0.1-0.5% NP-40 or Triton X-100) to solubilize membrane components without disrupting protein complexes

  • Pre-clearing Step: To reduce non-specific binding, pre-clear lysates with bare beads before adding YEL018C-A Antibody-conjugated beads, similar to techniques used in other antibody selection processes .

  • Controls: Include:

    • IgG isotype control to identify non-specific binding

    • Input samples to verify presence of target proteins

    • Reverse Co-IP with antibodies against suspected interaction partners

  • Elution Conditions: Optimize to ensure complete recovery without denaturing potential interacting partners.

Following these methodological considerations will enhance the specificity and reliability of Co-IP experiments using YEL018C-A Antibody.

What parameters should be optimized when using YEL018C-A Antibody in Western blot applications?

Optimizing Western blot protocols for YEL018C-A Antibody requires systematic adjustment of several parameters:

ParameterOptimization RangeConsiderations
Antibody Dilution1:500 - 1:2000Start with manufacturer's recommendation; titrate as needed
Blocking Solution3-5% BSA or non-fat milkBSA often preferred for phospho-specific detection
Incubation Time1-16 hoursLonger at 4°C may improve signal-to-noise ratio
Washing BufferTBS-T or PBS-T (0.05-0.1% Tween)Multiple washes reduce background
Detection MethodChemiluminescence, fluorescenceMatch sensitivity requirements
Membrane TypePVDF or nitrocellulosePVDF often provides better protein retention

For detecting low-abundance proteins, signal amplification systems may be considered, though these should be validated to ensure they don't introduce artifacts or non-specific signals.

How can researchers determine the appropriate YEL018C-A Antibody concentration for immunofluorescence studies?

Determining optimal antibody concentration for immunofluorescence requires a systematic titration approach:

  • Initial Range Finding:

    • Prepare a dilution series (typically 1:100 to 1:1000)

    • Test on positive control samples with known YEL018C-A expression

    • Include negative controls (secondary antibody only, isotype control)

  • Signal-to-Noise Evaluation:

    • Calculate signal-to-noise ratio at each concentration

    • Plot these values to identify the concentration yielding maximum specific signal with minimal background

  • Fixation Optimization:

    • Test multiple fixation methods (paraformaldehyde, methanol, acetone)

    • The target's subcellular localization may require specific permeabilization approaches

  • Incubation Parameters:

    • Evaluate both time (1-16 hours) and temperature (4°C, room temperature)

    • Longer incubations at lower temperatures often improve specificity

Similar to approaches used in antibody screening systems, researchers should consider implementing blocking steps with appropriate agents (5% normal serum from the same species as the secondary antibody) to minimize non-specific binding .

How can researchers address non-specific binding issues with YEL018C-A Antibody?

Non-specific binding is a common challenge when working with polyclonal antibodies like YEL018C-A Antibody. Several methodological approaches can minimize this issue:

  • Pre-adsorption Strategy:

    • Incubate antibody with lysate from YEL018C-A knockout yeast

    • This removes antibodies that bind to non-target proteins

    • After centrifugation, use the supernatant for your experiment

  • Modified Blocking Protocol:

    • Increase blocking reagent concentration (5-10%)

    • Extend blocking time (2-16 hours)

    • Add 0.1-0.5% Tween-20 to reduce hydrophobic interactions

  • Cross-Linking Validation:

    • Implement chemical cross-linking before immunoprecipitation

    • This preserves true interactions while allowing more stringent washing

  • Alternative Washing Buffers:

    • Incrementally increase salt concentration (150-500 mM NaCl)

    • Add low concentrations of SDS (0.1%) to reduce hydrophobic interactions

    • Use specialized buffers with mild detergents

Similar negative selection strategies have proven effective in other antibody applications to remove non-specific binders, such as incubating with bare beads prior to the actual selection process .

What analytical approaches help interpret data from experiments using YEL018C-A Antibody?

  • Quantitative Western Blot Analysis:

    • Use appropriate software (ImageJ, LI-COR Image Studio)

    • Normalize to loading controls (GAPDH, actin, total protein)

    • Account for background signal in calculations

    • Apply statistical tests appropriate for sample size and distribution

  • Validation Through Multiple Methods:

    • Confirm key findings using orthogonal techniques

    • For protein interactions, complement immunoprecipitation with techniques like proximity ligation assay

    • For expression studies, validate with RT-qPCR at the mRNA level

  • Dose-Response Assessment:

    • When studying effects of treatments on YEL018C-A expression

    • Plot concentration vs. response curves

    • Determine EC50/IC50 values where applicable

  • Time-Course Analysis:

    • For dynamic processes, collect multiple time points

    • Present data in time-dependent graphs

    • Consider rate of change as an analytical parameter

These analytical approaches enhance the rigor and reproducibility of research using YEL018C-A Antibody, similar to methodologies used in other antibody research contexts .

How can YEL018C-A Antibody be utilized in multiplexed immunoassays for systems biology applications?

Multiplexed immunoassays allow simultaneous detection of multiple targets, providing deeper insights into complex biological systems:

  • Bead-Based Multiplexing:

    • Conjugate YEL018C-A Antibody to spectrally distinct beads

    • Combine with antibodies against interacting proteins or pathway components

    • Analysis through flow cytometry provides quantitative multi-parameter data

    • This approach allows detection of multiple analytes from limited sample volumes

  • Microarray Integration:

    • Spot YEL018C-A Antibody alongside other antibodies on protein microarrays

    • Apply lysates from experimental and control conditions

    • Detect binding using fluorescently-labeled secondary antibodies

    • Analyze spot intensities to determine relative abundance across conditions

  • Sequential Elution Strategy:

    • For co-immunoprecipitation studies involving multiple potential interactors

    • Use buffers of increasing stringency to elute different binding partners

    • Analyze each fraction separately to identify stable versus transient interactions

These approaches enable comprehensive analysis of YEL018C-A in relation to other proteins, similar to advanced antibody screening platforms that employ multiple selection rounds with varied conditions .

What computational approaches can enhance analysis of YEL018C-A localization data?

Advanced computational methods can extract more information from localization experiments using YEL018C-A Antibody:

  • Machine Learning Classification:

    • Train algorithms to recognize subcellular patterns

    • Apply to large datasets for automated analysis

    • Identify subtle localization changes under different conditions

  • Colocalization Analysis:

    • Calculate Pearson's or Mander's coefficients for quantitative assessment

    • Use object-based approaches for discrete structures

    • Apply threshold corrections to account for background

  • 4D Analysis (3D + Time):

    • Track dynamic localization changes

    • Measure protein movement rates between compartments

    • Correlate with cellular events or cycle phases

  • Spatial Statistics:

    • Ripley's K-function for analyzing clustering patterns

    • Nearest neighbor analysis for distribution patterns

    • Fractal dimension analysis for complex distributions

These computational approaches significantly enhance the information extracted from imaging data, providing quantitative metrics for hypothesis testing rather than relying solely on qualitative assessments.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.